|Articles|April 15, 2002
- BioPharm International-04-01-2002
- Volume 15
- Issue 4
Advances in Amino Acid Analysis
Author(s)John C. Anders
by John C. Anders, AAI International With the advent of proteomics, innovative protein-based pharmaceuticals are entering the drug development pipeline. Compositional analysis, protein quantitation, and absorptivity determination by amino acid analysis ensures accurate characterization of recombinant proteins, amino acids, and peptides in development, bulk, and final products.
Advertisement
Articles in this issue
almost 24 years ago
Analytical Advances: Paperless or Less Paper?almost 24 years ago
Beyond QSITalmost 24 years ago
Determining Protein Concentration, Part 1: Methodologyalmost 24 years ago
Guest Editorial: The Protein Production Challengealmost 24 years ago
Business Matters: Personalized Medicine or Blockbusterology?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5
